Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Biomarkers
1.2.2. Imaging Technology
1.2.3. Application
1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for early diagnosis and personalized medicine
3.2.1.2. Advancements in imaging and molecular biomarker technologies
3.2.1.3. Regulatory approvals supporting clinical adoption
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of imaging equipment and diagnostic tests
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Middle East Imaging Biomarkers Market: Biomarkers Business Analysis
4.1. Segment Dashboard
4.2. Middle East Imaging Biomarkers Market Biomarkers Movement Analysis
4.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Biomarkers, 2021 to 2033(USD Million)
4.4. Anatomical Biomarkers
4.4.1. Anatomical Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Functional Biomarkers
4.5.1. Functional Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Molecular/Nuclear Biomarkers
4.6.1. Molecular/Nuclear Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Quantitative Imaging Biomarkers
4.7.1. Quantitative Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Others
4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Imaging Biomarkers Market: Imaging Technology Business Analysis
5.1. Segment Dashboard
5.2. Middle East Imaging Biomarkers Market Imaging Technology, Movement Analysis
5.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Imaging Technology, 2021 to 2033(USD Million)
5.4. MRI
5.4.1. MRI Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. CT
5.5.1. CT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. PET
5.6.1. PET Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. SPECT
5.7.1. SPECT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Ultrasound
5.8.1. Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Others
5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Imaging Biomarkers Market: Application Business Analysis
6.1. Segment Dashboard
6.2. Middle East Imaging Biomarkers Market Application Movement Analysis
6.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Application, 2021 to 2033(USD Million)
6.4. Diagnostics
6.4.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Drug Discovery & Development
6.5.1. Drug Discovery & Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Personalized Medicine
6.6.1. Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Disease Risk Assessment
6.7.1. Disease Risk Assessment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Imaging Biomarkers Market: End Use Business Analysis
7.1. Segment Dashboard
7.2. Middle East Imaging Biomarkers Market End Use Movement Analysis
7.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by End Use, 2021 to 2033(USD Million)
7.4. Hospitals
7.4.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Diagnostic/imaging centers
7.5.1. Diagnostic/imaging centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Pharmaceutical and Biotech Companies
7.6.1. Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Others
7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East Imaging Biomarkers Market: Country Estimates & Trend Analysis by Biomarkers, Imaging Technology, Application & End Use
8.1. Country Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. Middle east
8.3.1. Middle East Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. Saudi Arabia
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Saudi Arabia Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3. UAE
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. UAE Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.4. Kuwait
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Kuwait Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.5. Oman
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Oman Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.6. Qatar
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Qatar Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Participant’s Overview
9.4.1. GE HealthCare
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Biomarkers Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. FUJIFILM Holdings Corporation
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Biomarkers Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Siemens Healthineers AG
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Biomarkers Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Lunit Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Biomarkers Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Median Technologies
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Biomarkers Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. BioClinica Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Biomarkers Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. ICON plc
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Biomarkers Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Bracco
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Biomarkers Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Philips Healthcare
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Biomarkers Benchmarking
9.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
Table 4 Middle East imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
Table 5 Middle East imaging biomarkers market, by application, 2021 - 2033 (USD Million)
Table 6 Middle East imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
Table 7 Middle East imaging biomarkers market, by country, 2021 - 2033 (USD Million)
Table 8 Saudi Arabia imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
Table 9 Saudi Arabia imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
Table 10 Saudi Arabia imaging biomarkers market, by application, 2021 - 2033 (USD Million)
Table 11 Saudi Arabia imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
Table 12 UAE imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
Table 13 UAE imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
Table 14 UAE imaging biomarkers market, by application, 2021 - 2033 (USD Million)
Table 15 UAE imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
Table 16 Kuwait imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
Table 17 Kuwait imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
Table 18 Kuwait imaging biomarkers market, by application, 2021 - 2033 (USD Million)
Table 19 Kuwait imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
Table 20 Oman imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
Table 21 Oman imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
Table 22 Oman imaging biomarkers market, by application, 2021 - 2033 (USD Million)
Table 23 Oman imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
Table 24 Qatar imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
Table 25 Qatar imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
Table 26 Qatar imaging biomarkers market, by application, 2021 - 2033 (USD Million)
Table 27 Qatar imaging biomarkers market, by End Use, 2021 - 2033 (USD Million)
Table 28 Participant's overview
Table 29 Financial performance
Table 30 Key companies undergoing expansions
Table 31 Key companies undergoing acquisitions
Table 32 Key companies undergoing collaborations
Table 33 Key companies launching new products
Table 34 Key companies undertaking other strategies
List of Figures
Fig. 1 Imaging Biomarkers market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Middle East imaging biomarkers market driver analysis
Fig. 12 Middle East imaging biomarkers market restraint analysis
Fig. 13 Middle East imaging biomarkers market: Porter's analysis
Fig. 14 Middle East imaging biomarkers market: PESTEL analysis
Fig. 15 Middle East imaging biomarkers market: Biomarkers outlook and key takeaways
Fig. 16 Middle East imaging biomarkers market: Biomarkers market share analysis, 2023 - 2033
Fig. 17 Middle East imaging biomarkers by anatomical biomarkers market, 2021 - 2033 (USD Million)
Fig. 18 Middle East imaging biomarkers by functional biomarkers market, 2021 - 2033 (USD Million)
Fig. 19 Middle East imaging biomarkers by molecular/nuclear biomarkers market, 2021 - 2033 (USD Million)
Fig. 20 Middle East imaging biomarkers, by quantitative, 2021 - 2033 (USD Million)
Fig. 21 Middle East imaging biomarkers, by other market, 2021 - 2033 (USD Million)
Fig. 22 Imaging Biomarkers market: Imaging Technology outlook and key takeaways
Fig. 23 Imaging Biomarkers market: Imaging Technology market share analysis, 2023 - 2033
Fig. 24 Middle East imaging biomarkers by therapeutic drug monitoring market, 2021 - 2033 (USD Million)
Fig. 25 Middle East imaging biomarkers by MRI market, 2021 - 2033 (USD Million)
Fig. 26 Middle East imaging biomarkers by CT market, 2021 - 2033 (USD Million)
Fig. 27 Middle East imaging biomarkers by PET market, 2021 - 2033 (USD Million)
Fig. 28 Middle East imaging biomarkers by SPECT market, 2021 - 2033 (USD Million)
Fig. 29 Middle East imaging biomarkers by Ultrasound market, 2021 - 2033 (USD Million)
Fig. 30 Middle East imaging biomarkers by others market, 2021 - 2033 (USD Million)
Fig. 31 Imaging Biomarkers market: Application outlook and key takeaways
Fig. 32 Imaging Biomarkers market: Application market share analysis, 2023 - 2033
Fig. 33 Middle East imaging biomarkers by diagnostics market, 2021 - 2033 (USD Million)
Fig. 34 Middle East imaging biomarkers by Drug Discovery & Development market, 2021 - 2033 (USD Million)
Fig. 35 Middle East imaging biomarkers by Personalized Medicine market, 2021 - 2033 (USD Million)
Fig. 36 Middle East imaging biomarkers by Disease Risk Assessment market, 2021 - 2033 (USD Million)
Fig. 37 Middle East imaging biomarkers by others market, 2021 - 2033 (USD Million)
Fig. 38 Imaging Biomarkers market: End Use outlook and key takeaways
Fig. 39 Imaging Biomarkers market: End Use market share analysis, 2023 - 2033
Fig. 40 Middle East imaging biomarkers by hospitals market, 2021 - 2033 (USD Million)
Fig. 41 Middle East imaging biomarkers by diagnostics centres market, 2021 - 2033 (USD Million)
Fig. 42 Middle East imaging biomarkers by pharmaceutical and biotech companies market, 2021 - 2033 (USD Million)
Fig. 43 Middle East imaging biomarkers by others market, 2021 - 2033 (USD Million)
Fig. 44 Middle East imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 45 Saudi Arabia imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 UAE imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 Kuwait imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Qatar imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 49 Oman imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 50 Key company categorization
Fig. 51 Company market positioning
Fig. 52 Market participant categorization
Fig. 53 Strategy framework
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
